SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea · Delayed Price · Currency is KRW 2,045.00
-15.00 (-0.73%)
At close: Feb 11, 2026
SAMSUNG PHARM. Co., LTD. Market Cap
SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 192.48 billion as of February 11, 2026. Its market cap has increased by 34.72% in one year.
Market Cap
192.48B
Enterprise Value
n/a
Revenue
44.29B
Ranking
n/a
PE Ratio
15.14
Stock Price
2,045.00
Market Cap Chart
Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 192.48B, an increase of 976.20%. That is a compound annual growth rate of 8.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 192.48B | 33.66% |
| Dec 30, 2025 | 144.00B | -0.52% |
| Dec 30, 2024 | 144.76B | -0.84% |
| Dec 28, 2023 | 145.99B | -18.99% |
| Dec 29, 2022 | 180.22B | -45.48% |
| Dec 30, 2021 | 330.57B | -11.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 235.72B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| HLB Pharmaceutical | 230.15B |
| AptaBio Therapeutics | 225.03B |
| Samil Pharmaceutical Co.,Ltd | 221.21B |
| Jeil Pharmaceutical Co.,Ltd | 214.64B |
| REYON Pharmaceutical | 212.76B |
| JW Lifescience | 203.47B |